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Abstract
The cell wall is a vital and multi-functional part of bacterial cells. For Staphylococcus aureus, an important human
bacterial pathogen, surface proteins and cell wall polymers are essential for adhesion, colonization and during the
infection process. One such cell wall polymer, lipoteichoic acid (LTA), is crucial for normal bacterial growth and cell
division. Upon depletion of this polymer bacteria increase in size and a misplacement of division septa and eventual
cell lysis is observed. In this work, we describe the isolation and characterization of LTA-deficient S. aureus suppressor
strains that regained the ability to grow almost normally in the absence of this cell wall polymer. Using a whole
genome sequencing approach, compensatory mutations were identified and revealed that mutations within one gene,
gdpP (GGDEF domain protein containing phosphodiesterase), allow both laboratory and clinical isolates of S. aureus to
grow without LTA. It was determined that GdpP has phosphodiesterase activity in vitro and uses the cyclic
dinucleotide c-di-AMP as a substrate. Furthermore, we show for the first time that c-di-AMP is produced in S. aureus
presumably by the S. aureus DacA protein, which has diadenylate cyclase activity. We also demonstrate that GdpP
functions in vivo as a c-di-AMP-specific phosphodiesterase, as intracellular c-di-AMP levels increase drastically in gdpP
deletion strains and in an LTA-deficient suppressor strain. An increased amount of cross-linked peptidoglycan was
observed in the gdpP mutant strain, a cell wall alteration that could help bacteria compensate for the lack of LTA.
Lastly, microscopic analysis of wild-type and gdpP mutant strains revealed a 13–22% r e d u c t i o ni nt h ec e l ls i z eo f
bacteria with increased c-di-AMP levels. Taken together, these data suggest a function for this novel secondary
messenger in controlling cell size of S. aureus and in helping bacteria to cope with extreme membrane and cell wall
stress.
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Introduction
Staphylococcus aureus is a very prevalent human pathogen that
permanently colonizes the nares and skin of approximately 20% of
the population, while another 60% are colonized transiently [1].
Infections caused by this pathogen are becoming increasingly
more difficult to treat due to its resistance to antibiotic therapy.
Where once methicillin was the antibiotic of choice, now only
around 60% of S. aureus isolates remain sensitive to this drug.
There has also been a rise in the number of community acquired
methicillin resistant S. aureus (CA-MRSA) cases in recent years often
resulting in severe skin and soft tissue infections as well as invasive
diseases such as sepsis, necrotizing pneumonia or osteomyelitis
[2,3]. The ability of S. aureus to cause such a wide range of diseases
depends on many factors and is, in part, due to the diverse functions
that are linked to its cell envelope. A myriad of proteins are
embedded in this structure that allow bacteria to take up nutrients
and adhere to diverse surfaces or niches within the human host. It
also protects bacteria from environmental insults and at the same
time allows the cells to sense and respond to changes in their
surroundings, a function crucial for the survival of this pathogen in
the host. In addition, the cell wall helps bacteria to maintain their
shape and functions to counteract the high internal turgor pressure.
Because the cell envelope hassuchessential functions, it also forms a
weak point of the cell, as the inhibition of enzymes required for its
synthesis is often lethal or leads to virulence defects. Therefore, this
structure has been, and remains, an attractive target for therapeutic
interventions.
A typical cell wall of Gram-positive bacteria consists of proteins,
peptidoglycan (PG) and the cell wall polymers wall teichoic acid
(WTA), which is covalently linked to PG, and lipoteichoic acid
(LTA), a polymer anchored to the outside of the bacterial
membrane via a lipid moiety [4,5,6]. Synthesis of these cell wall
components is highly coordinated and any mistakes can lead to cell
lysis and death. From studies on the Gram-positive model organism
Bacillus subtilis, it has emerged that PG and WTA synthesis enzymes
form multi-protein complexes, which are further linked in this
organism with cytoplasmic cell shape determining proteins, thereby
coordinating and physically linking extracellular and intracellular
synthesis processes [7,8,9,10].
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linear chain of glycerolphosphate repeating units that is anchored
via a glycolipid to the membrane [11]. The glycerolphosphate
subunits are derived from the head group of the membrane lipid
phosphatidylglycerol and polymerized on the outside of the cell by
the membrane-linked lipoteichoic synthase enzyme LtaS to form
the backbone chain [12,13,14,15]. A large fraction of the
glycerolphosphate subunits are substituted with D-alanine resi-
dues, a modification known to play a key role in the resistance of S.
aureus and several other Gram-positive pathogens to cationic
antimicrobial peptides [16,17,18,19]. A function for this polymer
in the formation of biofilms has been identified and multiple
interactions between LTA and eukaryotic cells have been
described [20,21]. An interaction between LTA and macrophage
scavenger receptors is thought to occur and help the host to clear
bacterial infections [22,23]. In agreement with this suggestion,
scavenger receptor knockout mice are more susceptible to
infection with S. aureus [24]. This polymer has also been shown
to act as a ligand for Draper, a phagocytic receptor in Drosophila,
which upon binding of LTA results in the phagocytosis of S. aureus
by Drosophila hemocytes [25]. On the other hand, LTA is also
thought to act as an anti-inflammatory molecule on skin cells by
suppressing the TLR-3-mediated responses upon skin injury, a key
pathway in the induction of inflammation [26].
Recently defined mutants lacking the entire LTA polymer have
been constructed and phenotypic analysis indicated an important
role for this polymer for normal bacterial growth and morphology
[13,27,28,29,30]. LTA-deficient S. aureus strains have severely
impaired growth and can initially only be propagated in medium
containing high salt or sucrose concentrations, which are thought
to act as osmoprotectants, or at low temperature [13,27]. Even
under conditions permissive for growth, these cells have severe
morphological defects, such as an increased cell size and the
tendency to clump. In addition, misplacement of cell division septa
is observed, highlighting that the lack of LTA on the outside of the
cell negatively affects fundamental processes in the cytoplasm of
the cell. However, it is currently not known how these processes
are coordinated.
In this study we set out to investigate if S. aureus can find a way
to survive without LTA and identified LTA-deficient suppressor
strains that can grow and divide almost normally in the absence of
this multi-functional cell wall polymer. Using a whole genome
sequencing approach, it was determined that these strains have
acquired mutations in a gene encoding a protein named GdpP (for
GGDEF domain protein containing phosphodiesterase). We show
that as a consequence of this mutation, the intracellular levels of
the novel cyclic dinucleotide c-di-AMP increase drastically in the
suppressor strain and gdpP mutant laboratory or CA-MRSA
strains. This provides the first experimental evidence that c-di-
AMP is produced in S. aureus and that GdpP functions as a c-di-
AMP phosphodiesterase in vivo. With this study we provide
information on one of the first functions of this novel secondary
messenger, which is in helping bacteria to cope with extreme cell
wall stress in addition to controlling the cell size of S. aureus, as
revealed by microscopic analysis.
Results
Construction of an LTA negative S. aureus RN4220 strain
In order to determine whether it is possible for S. aureus to
compensate for the cell wall stresses introduced by deleting LTA,
the RN4220-derived ltaS deletion strains SEJ1DltaSN and SEJ1Dl-
taSS were created and the lack of LTA confirmed by western blot
(Figure S1A in Text S1, data not shown). These strains were
constructed under high osmotic conditions in medium containing
7.5% NaCl (N) or 40% sucrose (S) that are, as previously shown,
permissive for growth of S. aureus in the absence of LTA (Figure
S1B in Text S1) [27]. However, in contrast to this previous study
[27], growth of our ltaS deletion strains were dependent on
osmoprotectants at both 30uC and 37uC. Plating efficiencies for
the DltaSN strain decreased from 3.5610
8 CFU/ml on 7.5% NaCl
containing TSA plates to 8610
1 CFU/ml on TSA plates at 37uC
and similar low CFUs were obtained at 30uC. SEJ1DltaS bacteria
had aberrant cell morphologies even under conditions permissive
for growth and displayed an enlarged cell size, a tendency to
cluster and a misplacement of division sites (Figure 1C) [13,27]. In
summary, our LTA-negative S. aureus RN4220 strains are viable
under osmotically stabilizing conditions but not in TSB medium
and display the expected morphological and cell division defects.
Characterization of S. aureus suppressor strains that can
grow without LTA
When SEJ1DltaS strains were plated on TSA plates without the
additionof sucroseor salt a small numberof colonies wereobtained.
We hypothesized that these colonies arose from bacteria that had
acquired compensatory mutation(s) that allow bacteria to grow in
the absence of LTA. To analyze this further, five independently
isolated suppressor colonies were passed four times in TSB to
improve growth. As expected, LTA was still absent in the five
suppressor strains 4S4, 4S5, 4N1, 4N2 and 5S4 (Figure 1A),
however growth of these strains now more closely resembled that of
the parental strain SEJ1 (Figure 1B). Examination of the five
suppressor strains by phase contrast and fluorescence microscopy
revealed a near WT cell size and a considerable improvement in the
accuracy of division site placement, although misplacement of septa
still occurred in some cells (Figure 1C).
To further investigate the cell wall properties of these LTA-
negative suppressor strains additional assays were performed. The
suppressor strains were two to four-fold more susceptible to
lysostaphin, nisin, vancomycin, oxacillin, penicillin G and dapto-
mycin (Table S1 in Text S1). In addition, the suppressor strains
lysed faster than the control strain in autolysis assays (Figure S2A in
Author Summary
Staphylococcus aureus is an important human pathogen
that colonizes the nares and skin of both sick and healthy
individuals and causes a variety of infections ranging from
superficial skin to invasive infections. The ability of this
bacterium to cause disease depends on many factors and
is, in part, due to multi-functional cell surface structures.
One such structure is lipoteichoic acid (LTA), which is
crucial for bacterial growth. In this study we show that LTA
is also important for growth of a clinically relevant
community-acquired methicillin resistant S. aureus (CA-
MRSA) strain and not only for laboratory strains as
previously described. We set out to investigate if S. aureus
can find a way to survive without LTA and identified strains
that can grow and divide almost normally in its absence.
Using a whole genome sequencing approach, we found
that alterations in one gene, gdpP, allow these strains to
grow in the absence of LTA. We show that this mutation
causes an increase in the recently identified signaling
molecule, c-di-AMP, within the cell. Therefore, with this
study we provide information on one of the first functions
of this novel secondary messenger, which is in helping
bacteria to cope with extreme cell wall stress.
c-di-AMP Permits S. aureus Growth without LTA
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hydrolytic enzymes as determined by zymogram assays (Figure S2B
in Text S1). LTA production was restored in two suppressor strains,
4S5 and 5S4, by introducing the complementation vector pCN34-
ltaS. The amount of cell-associated hydrolytic enzymes increased in
these strains (FigureS2Cin Text S1), suggesting that LTAhasa role
in regulating autolysin levels. This is supported by the observations
of Okuet al [27] who notedan even greater reduction inthe amount
of autolysins for their ltaS mutant strain, which could again be
complemented. Taken together, S. aureus suppressor strains that can
grow in the absence of LTA can be isolated readily and the
morphology and cell division pattern defects are significantly
improved in these strains. However, differences in autolysis and
susceptibility to cell wall active antibiotics are indicative of re-
maining changes in the cell wall properties of these strains.
Identification of mutations in LTA-negative S. aureus
suppressor strains
It seems likely that the LTA-negative S. aureus suppressor strains
4S4, 4S5, 4N1, 4N2 and 5S4 have acquired mutations elsewhere
on the chromosome that allow for improved cell division and
growth. A whole genome sequencing approach was used to
identify such sequence alterations (for details see materials and
methods section). In total, ten genes within these five strains
contained mutations with high confidence scores. Five of these
mutations were discarded as they were also present in strain
SEJ1DltaS pCN34-ltaS, an intermediate strain used for the
construction of the ltaS deletion strains that still contains an intact
copy of the ltaS gene. It is likely that these mutations were
introduced during the temperature shift necessary to create the ltaS
deletion.Themutationsinthe remainingfivegeneswereatdifferent
positions and consisted of nonsense mutations, amino acid sub-
stitutions or DNA inversions (Table 1). The five genes included
SAOUHSC_00015, a conserved hypothetical protein with putative
diguanylate cyclase and phosphoesterase activity and the only gene
mutated in all five suppressor strains; SAOUHSC_01104, encoding
for the succinate dehydrogenase SdhA, a TCA cycle enzyme;
SAOUHSC_01358, which encodes for a putative permease;
SAOUHSC_02001, a conserved hypothetical protein with weak
homology to a fusaric acid transporter, and SAOUHSC_02407, a
conserved hypothetical protein with homology to DisA, a DNA
integrity scanning protein from B. subtilis. In each suppressor strain
two to four of these five genes were mutated and all mutations were
confirmed by re-sequencing all five genes in each suppressor strain.
As mentioned above, the suppressor strains were passed
four times in broth culture to improve growth before phenotypic
and sequence analysis. Therefore, one or more of the mutations
listed in Table 1 may have arisen during the passing steps to aid
with growth and not as a direct consequence of assisting growth
of the LTA-negative strains. To address this, chromosomal DNA
was isolated from the original suppressor colonies of strains 4S4,
4S5, 4N1, 4N2 and 5S4 and the five genes in question were
sequenced. Only the mutations in gene SAOUHSC_00015 were
present in all five strains. Thus, it appears that inactivation of
Figure 1. Characterization of DltaS suppressor strains. (A) LTA detection by western blot. Cell-associated LTA isolated from strain SEJ1 (WT)
and the five suppressor strains (4S4, 4S5, 4N1, 4N2 and 5S4) was analyzed by western blot. The positions of protein molecular mass markers (in kDa)
are indicated on the left. (B) Bacterial growth curves. Overnight cultures of SEJ1 (WT) and the five suppressor strains (4S4, 4S5, 4N1, 4N2 and 5S4) were
grown in TSB. Strain SEJ1DltaSN (DltaSN) was grown overnight in TSB 7.5% NaCl. All cultures were washed 3 times in TSB and diluted to a starting
OD600 of 0.05 in TSB. Growth was monitored over a 10 h period. (C) Microscopic analysis of WT and LTA-negative strains. SEJ1 (WT) and the LTA-
negative strains (4S4, 4S5, 4N1, 4N2 and 5S4) were grown in TSB to log-phase and strains SEJ1DltaSN (DltaSN) and SEJ1DltaSS (DltaSS) were grown in
TSB containing 7.5% NaCl or 40% sucrose, respectively. Samples were prepared for microscopy analysis and bacteria stained with BODIPY-
vancomycin as described in the materials and methods section.
doi:10.1371/journal.ppat.1002217.g001
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(for GGDEF domain protein containing phosphodiesterase), com-
pensates for the lack of LTA. The remaining mutations in the
four other genes are possibly accessory and function to improve
growth.
Disruption of gdpP allows for the growth of an LTA-
deficient strain of S. aureus
If disruption of gdpP compensates for a lack of LTA, one would
predict that introducing a WT copy of gdpP into a suppressor strain
should be lethal, while the introduction of any of the mutant gdpP
alleles present in the suppressor strains should not prevent growth.
This was indeed the case, and the expression of WT gdpP from an
anhydrotetracycline (Atet) inducible promoter containing plasmid
but not the expression of the mutant gdpP alleles obtained from
suppressor strains 4S4 (inverted sequence, inframe), 4S5 (point
mutation) or 4N2 (stop codon) prevented growth of strain 4S5
(Figure 2B). As controls, introduction of the empty vector
pCN34iTET or uninduced pCN34iTET-gdpP into the suppressor
strain 4S5 had no effect on bacterial growth (Figure 2A, left panel)
and expression of GdpP in WT SEJ1 also had no effect on growth,
demonstrating that expression of GdpP is not toxic per se
(Figure 2A, right panel). These results provide further evidence
that disruption of gdpP is essential for the survival of LTA-negative
S. aureus suppressor strains. However, the suppressor strains
contain other known mutations (see text and Table 1), therefore
we set out to recreate the system in an S. aureus strain without these
additional mutations. To this end, the S. aureus strain SEJ1DgdpP-
iltaS with a silent gdpP deletion and IPTG inducible ltaS expression
was created (Figure 3A). Normally, the growth of an inducible ltaS
strain is dependent on IPTG [13], however this should no longer
be the case upon deletion of gdpP and expression of GdpP from a
plasmid should restore IPTG-dependent growth to this strain. S.
aureus strains SEJ1-iltaS pCN34 (iltaS pCN34) and SEJ1DgdpP-iltaS
containing the GdpP expression plasmid (DgdpP iltaS pCN34iTET-
gdpP) were used to test this experimentally. All strains grew in the
Table 1. Mutations present in SEJ1DltaS suppressor strains.
S. aureus NCTC8325 gene number
Strain SAOUHSC_00015 SAOUHSC_01104 SAOUHSC_01358 SAOUHSC_02001 SAOUHSC_02407
4S4 Inverted 18,924–19,002
(AA203–227 flipped)
C 1,065,691 G (Thr119Arg) C 1,300,654 G (Pro287Arg) WT C 2,235,383 A (Leu193Phe)
4S5 G 19,114 A (Gly266Asp) WT G 1,300,870 A (Gly359Asp) WT WT
4N1 A insertion 19,209 (Asn300stop) WT A 1,299,810 T (Lys6stop) WT G 2,235,253A (Thr236Ile)
4N2 Inverted 19,477–19,758 (Ile416stop) WT WT A 1,911,510 T (Arg207stop) WT
5S4 Deleted T 19,205 (Val319stop) WT C 1,300,642 T (Pro283Leu) C 1,911,723 T (Gln278stop) WT
Numbers indicate site of base substitutions in the respective SEJ1DltaS suppressor strain as compared to the SEJ1DltaS reference strain sequence with numbers given
based on the S. aureus NCTC8325 genome sequence. Resulting amino acid changes in corresponding proteins are shown in parenthesis. WT indicates that the
sequences were identical between SEJ1DltaS reference strain and suppressor strain.
doi:10.1371/journal.ppat.1002217.t001
Figure 2. Expression of different gdpP alleles in an LTA-negative suppressor strain and their effect on growth. (A) Serial dilutions
(indicated on the left) of WT SEJ1 containing the Atet-inducible GdpP expression vector (WT pCN34iTET-gdpP), the suppressor strain 4S5 containing
the empty vector (4S5 pCN34iTET) or the GdpP expression vector (4S5 pCN34iTET-gdpP) were spotted on TSA plates containing either no (left panel)
or 200 ng/ml Atet (right panel). (B) The mutated gdpP alleles from suppressor strains 4S4, 4S5 and 4N2 (indicated above panel) were expressed from
pCN34iTET in the strain 4S5. Serial dilutions of were spotted on TSA 200 ng/ml Atet plates to induce protein expression from the plasmid vector.
doi:10.1371/journal.ppat.1002217.g002
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(Figure S3A in Text S1) and displayed a normal cell shape and
placement of division septa (Figure 3B and S3B in Text S1, panels
i, iv & vii). It is interesting to note that SEJ1DgdpP-iltaS bacteria,
which contain a deletion of the gdpP gene, appear to have a
reduced cell size (Figure 3B, iv & vii) and this will be analyzed in
more detail later on. In the absence of IPTG, LTA was no longer
produced (Figure S3A in Text S1) and as expected growth of the
inducible ltaS strain ceased (Figure 3C, iltaS pCN34 – white and
grey filled squares). Morphologically the cells appeared enlarged,
clumped and showed aberrant cell division (Figure 3B and S3B in
Text S1, panels ii & iii). However, as predicted growth of the
inducible ltaS strain with the gdpP deletion continued even in the
absence of IPTG (Figure 3C, DgdpP-iltaS pCN38 – white and grey
filled triangles) and the morphology of the cells was much
improved showing more regular cell sizes and division (Figure 3B
and S3B in Text S1, panels v, vi & viii). Addition of Atet (grey
symbols) for the expression of GdpP from the complementation
vector restored the IPTG-dependent growth phenotype and strain
SEJ1DgdpP-iltaS pCN34iTET-gdpP ceased to grow in the absence
of IPTG (Figure 3C, DgdpP iltaS pCN34iTET-gdpP - grey circles)
and cells displayed an aberrant morphology (Figure 3B and S3B in
Text S1, panel ix). In summary, it can now be concluded that
deleting the gdpP gene allows for the growth of an LTA-deficient
strain of S. aureus.
LTA is important for growth of a clinical isolate of
S. aureus and disruption of gdpP can compensate for the
growth inhibition
The experiments described above confirm that deletion of gdpP
compensates for the lack of LTA in an RN4220-derived S. aureus
strain. However, this strain is a chemically mutagenized laboratory
strain that contains known mutations and defects in regulatory
systems [31,32,33,34]. To determine if LTA is also important for
growth of other S. aureus isolates, and whether mutations in gdpP
Figure 3. Deletion of gdpP can rescue the dependence of RN4220iltaS on IPTG. (A) Schematic representation of S. aureus strain SEJ1DgdpP-
iltaS pCN34iTET-gdpP, containing an inframe gdpP deletion, the ltaS gene under IPTG inducible Pspac control and the complementing vector
pCN34iTET-gdpP. The effects of the addition of the inducers on the production of LTA and GdpP are indicated. (B) Microscopic analysis of strains
RN4220iltaS pCN34 (iltaS pCN34; i–iii), SEJ1DgdpP-iltaS pCN38 (DgdpP-iltaS pCN38; iv–vi) and SEJ1DgdpP-iltaS pCN34iTET-gdpP (DgdpP-iltaS
pCN34iTET-gdpP; vii–ix). Strains were grown overnight in the presence of IPTG, washed and grown for 8 h in TSB containing 1mM IPTG (left panel),
TSB (no inducer – middle panel) or TSB containing 100 ng/ml Atet (right panel). Bacteria were stained with BODIPY-vancomycin and prepared for
microscopy analysis as described in the materials and methods section. Larger fields of view are shown in Figure S3B in Text S1 (C) Bacterial growth in
the presence or absence of inducer. Strains RN4220iltaS pCN34 (iltaS pCN34), SEJ1DgdpP-iltaS pCN38 (DgdpP-iltaS pCN38) and SEJ1DgdpP-iltaS
pCN34iTET-gdpP (DgdpP-iltaS pCN34iTET-gdpP) were grown overnight in the presence of IPTG, washed and diluted in either TSB containing 1mM
IPTG +100 ng/ml Atet (black symbols), TSB containing 100 ng/ml Atet (grey symbols) or just plain TSB (no inducer – white symbols). After 4 h cultures
were diluted 1:100 into fresh medium to maintain them in the exponential growth phase and this OD600 is plotted as T=0. Growth was then
continued for a further 6 h. Growth curves were performed in triplicate and the average and standard deviations were plotted.
doi:10.1371/journal.ppat.1002217.g003
c-di-AMP Permits S. aureus Growth without LTA
PLoS Pathogens | www.plospathogens.org 5 September 2011 | Volume 7 | Issue 9 | e1002217can compensate for the lack of LTA, the ltaS gene was deleted in
the erythromycin sensitive community-acquired MRSA (CA-
MRSA) strain LAC* [35]. Strains LAC*DltaSN::erm and LAC*Dl-
taSS::erm with complete ltaS deletions could be obtained on TSA
plates containing 7.5% NaCl or 40% sucrose and the absence of
LTA was confirmed by western blot (Figure 4A). Both LAC*Dlta-
S::erm strains could initially only grow in the presence but not in
the absence of osmoprotectants (Figure 4B). Identical to the
RN4220 ltaS-deletion strains, LAC*DltaS::erm suppressor colonies
could be obtained on TSA plates. These strains did not produce
LTA but were now able to grow in the absence of osmoprotectants
(Figure 4). To establish whether the LAC*DltaS::erm suppressor
strains had acquired mutations within gdpP, this gene was
sequenced from eight independently isolated suppressor strains.
Of these eight strains, five had mutations in the gdpP gene (Table
S2 in Text S1). These results show that LTA is also important for
the growth of a CA-MRSA strain and indicate that, as observed in
RN4220, inactivation of gdpP provides a mechanism that allows
LAC* to grow in the absence of LTA.
S. aureus GdpP has in vitro c-di-AMP phosphodiesterase
activity
S. aureus GdpP contains two N-terminal transmembrane helices
followed by a degenerated PAS sensory domain (Pfam00989), a
GGDEF domain (Pfam00990), a DHH domain (Pfam01368) and
a DHH-associated DHHA1 domain (Pfam02272) (Figure 5A).
GGDEF domains are usually associated with proteins containing
c-di-GMP cyclase or phosphodiesterase activity [36,37] and
DHH/DHHA1 domain-containing proteins often function as
phosphatases or phosphoesterases [38]. The B. subtilis protein
YybT is a close homologue to S. aureus GdpP and recently it was
shown that recombinant B. subtilis YybT has strong phosphodi-
esterase activity contained within the DHH/DHHA1 domains
[39]. It was further suggested that the cyclic dinucleotide c-di-
AMP is the physiological substrate and is converted to 59-pApA by
YybT [39]. In addition, it was found that the GGDEF domain of
YybT has weak ATPase activity but no c-di-GMP or c-di-AMP
cyclase activity [39]. To investigate whether S. aureus GdpP, like B.
subtilis YybT, is a c-di-AMP phosphodiesterase an N-terminally
His-tagged fragment of GdpP spanning amino acids 84–655 and
containing the PAS, GGDEF and DHH/DHHA1 domains was
expressed and purified from E. coli extracts (Figures 5A and S4 in
Text S1). Incubation of c-di-AMP with the recombinant rGdpP84–
655 protein resulted in the complete conversion of c-di-AMP to 59-
pApA. This was initially determined by mass spectrometry analysis
(data not shown) and subsequently quantified by separating
reaction products by HPLC and integrating the nucleotide peak
areas using c-di-AMP and 59-pApA standards as controls
(Figure 5B). Recombinant rGdpP84-301 protein containing only
the PAS and GGDEF domains was also used in this assay and
even when present in 4-fold higher amounts did not show any
phosphodiesterase activity (Figure 5B). Therefore, identical to B.
subtilis YybT, recombinant S. aureus GdpP has in vitro c-di-AMP
phosphodiesterase activity and the DHH/DHHA1 domain is
essential for this activity. Purified S. aureus rGdpP84–655 did not
show any, or at the most very weak, ATPase activity in vitro (data
not shown). However reaction conditions were not further
optimized, as the phosphodiesterase activity appears to be the
biologically relevant activity (see below).
Disruption of the c-di-AMP phosphodiesterase activity of
GdpP is essential for the survival of LTA-negative
S. aureus strains
The gdpP mutations present in three of the five sequenced
RN4220 LTA suppressors (4N1, 4N2 and 5S4) lead to stop codons
in or before the DHH/DHHA1 domain, which will automatically
disrupt the phosphodiesterase activity (Figure 5A). On the other
hand, the gdpP mutations in 4S4 and 4S5 lead to the expression of
GdpP variants with a 24 amino acid inversion (but still in frame)
and a G266D amino acid substitution. To test if these alterations
Figure 4. Growth and LTA production of CA-MRSA LAC* and
LAC*DltaS strains. (A) LTA detection by western blot. S. aureus LAC*
(WT) and the eight suppressor strains UN1, UN2, UN3, UN4, US1, US2,
US3 and US4 were grown in TSB. LAC*DltaSN::erm was grown in TSB
containing 7.5% NaCl and LAC*DltaSS::erm in TSB containing 40%
sucrose and LTA detected by western blot. (B) and (C) Bacterial growth
curves. Overnight cultures of strains described above were washed 3
times and diluted to a starting OD600 of 0.05 in TSB and OD600 readings
determined every 2 h for 10 h.
doi:10.1371/journal.ppat.1002217.g004
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(comprising amino acids 84–655) were produced (Figure S4 in
Text S1) and the phosphodiesterase activity measured. While all of
the input c-di-AMP was hydrolyzed by WT rGdpP84–655 in less
than ten minutes, recombinant rGdpP4S4 and rGdpP4S5 variants
converted less than 40% of the input substrate to 59-pApA in one
hour (Figure 5C). These results provide evidence that a disruption
of the phosphodiesterase function of GdpP is responsible for
compensating for a lack of LTA in suppressor strains.
In B. subtilis YybT, amino acids D225 and R291 in the GGDEF
domain and residues D420 and D499 in the DHH/DHHA1 were
identified as key residues for the weak ATPase activity and the
phosphodiesterase activity, respectively [39]. Alanine substitutions
at the corresponding positions D223, R289, D418 and D497 in S.
aureus GdpP (Figure 5A) were made and recombinant proteins
expressed and purified (Figure S4 in Text S1) for use in in vitro
phosphodiesterase assays or were expressed from the Atet-inducible
vector pCN34iTET in S. aureus strain 4S5 in order to investigate
which activity needs to be inactivated to allow for the survival
of the LTA-negative suppressor strain. As expected, recombinant
rGdpPD418A and rGdpPD497A with substitutions of key residues in
the DHH/DHHA1 domains lacked phosphodiesterase activity
(Figure 6A). Interestingly, the rGdpPR289A variant with a substitu-
tion in the GGDEF domain also had reduced in vitro phosphodi-
esterase activity, while the activity of the rGdpPD223A enzyme was
identical to WT rGdpP84–655 (Figure 6A). The survival of the LTA-
negative suppressor correlated with the defect in phosphodiesterase
activity as expression of GdpPR289A, GdpPD418A or GdpPD497A did
not affect the growth of strain 4S5, while expression of GdpPD223A
with WT phosphodiesterase activity prevented the growth of this
strain (Figure 6B). Therefore, the ability of S. aureus to grow in the
absence of LTA seems to be independent of any potential ATPase
activity GdpP may have, but the survival depends on the disruption
of the phosphodiesterase activity and possibly a concurrent increase
in c-di-AMP concentration in the cell.
The S. aureus enzyme DacA is a c-di-AMP cyclase
Our results thus far have shown that GdpP has in vitro c-di-AMP
phosphodiesterase activity. For this activity to be of any biological
significance, S. aureus needs to be able to synthesize c-di-AMP.
Until now, c-di-AMP has only been described as a naturally
occurring molecule in the supernatant of Listeria monocytogenes
cultures and in two very recent studies in the cytoplasm of B.
subtilis and Streptococcus pyogenes [40,41,42]. The c-di-AMP in the
supernatant of L. monocytogenes was shown to be involved in the
activation of an IFN-b-mediated host immune response [40]. In
the same study, a L. monocytogenes protein thought to be essential for
bacterial growth and containing a so called DisA_N or DAC
domain (Pfam02457) was implicated in the production of c-di-
AMP and termed DacA for diadenylate cyclase A [40]. The S.
aureus membrane protein SAOUHSC_02407 is homologous to this
L. monocytogenes protein and the only S. aureus protein that contains
a DisA_N domain. Of note, this gene is also one of the five genes
found to contain mutations within two of the SEJ1DltaS suppressor
strains (Table 1).
To investigate if SAOUHSC_02407 is a c-di-AMP cyclase, this
gene was cloned and expressed in E. coli, which cannot naturally
produce c-di-AMP. E. coli extracts were prepared and analyzed by
LC-MS/MS as previously described for the detection of c-di-GMP
[43]. While no c-di-AMP was detected in E. coli extracts isolated
from a strain containing the empty plasmid pET28b, extremely
high levels of more than 2800 ng c-di-AMP/mg E. coli protein
were detected in extracts isolated from the strain expressing
SAOUHSC_02407 (Figure 7A). This provides experimental
Figure 5. In vitro phosphodiesterase activity of WT and mutant
GdpP variants. (A) Schematic representation of the GdpP protein. The
N-terminus of the protein contains 2 transmembrane helices (black
boxes), a degenerate PAS domain (residues 83–159), a GGDEF domain
(residues 171–301), a DHH domain (residues 331–501) and a DHHA1
domain (residues 588–643). Protein domains expressed as recombinant
proteins are indicated by the thick black lines. Amino acids mutated to
alanines by site-directed mutagenesis are indicated by grey circles and
residues altered in suppressor strains are indicated by a grey star (amino
acid substitution – 4S5), by black arrows (stop codons – 4N1, 4N2 and
5S4) or by a triangle (inframe amino acid inversion – 4S4). (B) and (C)
Phosphodiesterase activity of rGdpP proteins. (B) Enzyme reactions
were set up in assay buffer containing 20 mM c-di-AMP and either no
enzyme (no enz.), 1 mMr G d p P 84–655,1 mMr G d p P 84–301 or 4 mM
rGdpP84–301. Reactions were stopped after 60 min and% c-di-AMP
hydrolysis calculated based on nucleotide peak areas following HPLC
separation. (C) Enzyme reactions were set up as described above using
the recombinant GdpP variants indicated in the legend. Reactions were
stopped after 3, 10, or 60 min and% c-di-AMP determined as described
above. Four independent experiments were performed and the average
value and standard deviation plotted.
doi:10.1371/journal.ppat.1002217.g005
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DacA, is a c-di-AMP cyclase and that S. aureus should be capable of
producing c-di-AMP.
Inactivation of GdpP results in increased intracellular
c-di-AMP levels
To address experimentally if c-di-AMP is produced by S. aureus
and to investigate the involvement of GdpP in adjusting nucleotide
levels, cytoplasmic extracts were prepared from cultures of strains
SEJ1 and the gdpP mutant SEJ1DgdpP::kan. C-di-AMP could be
readily detected in samples isolated from both strains using an LC-
MS/MS method [43]. To accurately quantify c-di-AMP levels,
samples were spiked before extraction with a
13C
15N isotope-
labeled version of c-di-AMP of known concentration and amounts
were quantified based on a c-di-AMP standard curve (Figure S5 in
Text S1). A c-di-AMP concentration of 3.3360.44 ng/mg bacterial
dry weight was determined for strain SEJ1 and upon deletion of
gdpP the c-di-AMP levels increased more than 13-fold to
45.3763.83 ng/mg bacterial dry weight (Figure 7B). An increase
in c-di-AMP concentration of a similar magnitude was also
observed when samples were prepared from the LTA-negative
suppressor strain 4S5 (Figure 7B). Furthermore, c-di-AMP was also
detected in cytoplasmic extracts of the CA-MRSA strain LAC* and
again the c-di-AMP levels increased more than 11-fold in the
isogenic gdpP deletion strain LAC*DgdpP::kan (Figure 7B). These
results establish for the first time the presence of the cyclic
dinucleotide c-di-AMP in S. aureus, and provide direct evidence that
the S. aureus GdpP enzyme is a c-di-AMP specific phosphodiesterase
in vivo. In addition, these results demonstrate that S. aureus strains
that lack LTA respond by increasing cellular levels of the secondary
messenger c-di-AMP. It is also important to note that no
Figure 6. Disruption of GdpP phosphodiesterase activity
compensates for a lack of LTA. (A) Phosphodiesterase activity of
different rGdpP variants. Enzyme reactions were set up in assay buffer
containing 20 mM c-di-AMP and 1 mM of the recombinant rGdpP
variants indicated in the legend. Reactions were stopped after 3, 10, or
60 min and% c-di-AMP determined based on nucleotide peak areas
following HPLC separation. Four independent experiments were
performed and the average value and standard deviation plotted. (B)
Bacterial growth assay. Alanine substituted GdpP variants were
expressed from pCN34iTET in the suppressor strain 4S5. Serial dilutions
of 4S5 containing the plasmid indicated above the panel were spotted
on TSA plates containing 200 ng/ml Atet.
doi:10.1371/journal.ppat.1002217.g006
Figure 7. Intracellular c-di-AMP detection. (A) Intracellular c-di-
AMP concentration of E. coli strains BL21(DE3) harboring the empty
vector pET28b or the DacA expression vector pET28b-dacA. E. coli
strains were grown and cell extracts prepared as described in the
materials and methods section. c-di-AMP concentrations were deter-
mined by HPLC-MS/MS analysis and the average and standard deviation
of three values plotted as ng c-di-AMP/mg E. coli protein. (B) The
concentration of c-di-AMP in the cytoplasm of WT strains SEJ1 and LAC*
(black bars), the gdpP mutant strains SEJ1DgdpP::kan and LAC*DgdpP::-
kan (grey bars) and the SEJ1-derived suppressor strain 4S5 (striped bar)
were quantified by HPLC-MS/MS. Cyclic dinucleotide concentrations are
presented as ng c-di-AMP/mg bacterial dry weight and the average and
standard deviation of three values are plotted.
doi:10.1371/journal.ppat.1002217.g007
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extracts as judged by LC-MS/MS. This is consistent with the
findings by Holland et al. [44], that GdpS (GGDEF domain protein
from Staphylococcus), the only staphylococcal protein with a
potentially intact GGDEF domain, is unable to synthesize c-di-
GMP. Taken together, our findings indicate that c-di-GMP is
absent in S. aureus but underscores the importance of c-di-AMP as a
secondary messenger in S. aureus.
Increased c-di-AMP levels influence cell size and
envelope characteristics
To examine whether a deletion of gdpP, and the concomitant
increase in c-di-AMP, directly affects cell wall properties and could
in that way compensate for the lack of LTA, the cell wall
characteristics of the mutant strains were examined. Firstly the
level of hydrolytic enzymes present on the cell surface of LAC*
and the isogenic gdpP mutant was analyzed. The gdpP mutant
strain possessed increased amounts of autolysins as judged by
zymographic analysis (Figure S6 in Text S1).
Next LAC* and the isogenic LAC*DgdpP::kan mutant strain
were incubated with increasing concentrations of the cell wall or
membrane targeting antimicrobials oxacillin, penicillin G, vanco-
mycin, lysostaphin, daptomycin and nisin. LAC*DgdpP::kan dis-
played an approximately eight-fold decreased susceptibility to
oxacillin and lysostaphin and a more than 32-fold decreased
susceptibility to penicillin G (Table 2), indicating that changes in
the cell wall/peptidoglycan structure have occurred. To investi-
gate this further, peptidoglycan was purified from the WT and the
gdpP mutant LAC* strains, digested with mutanolysin and the
muropeptides analyzed by HPLC. The overall muropeptide
profile of the two strains was very similar (Figure S7A and B in
Text S1), however a statistically significant reduction in the
amount of monomeric muropeptides and a concurrent increase in
higher cross-linked muropeptides (trimers and above) was
observed in the gdpP mutant strain (Figure 8A). This increase in
the amount of cross-linked peptidoglycan could potentially be
responsible for the increased resistance to cell wall targeting
antimicrobials observed in this strain and could aid with bacterial
survival in the absence of LTA by strengthening the cell wall,
however this is speculative and remains to be confirmed.
Following this, the WT LAC* strain and the isogenic
LAC*DgdpP::kan strain were grown to mid-log phase, stained with
BODIPY-vancomycin and observed under the microscope. This
analysis revealed a reduction of cell size by more than 13% for the
gdpP mutant, which could be restored to the WT cell size upon
complementation with gdpP (Figure 8B and S7C in Text S1). Based
on this microscopic analysis, average diameters of 1.18860.025 mm
and 0.96760.015 mm were determined for the LAC* and
LAC*DgdpP::kan strains, respectively (Table 3). A similar reduction
in cell size was observed for the gdpP mutant in the RN4220 strain
background, where cell diameters of 1.13860.081 mm for SEJ1 and
0.87960.051 mm for the SEJ1DgdpP::kan strain were measured.
These results indicate a function for c-di-AMP in controlling the cell
size of S. aureus with increased cyclic dinucleotide levels leading to a
statistically significant decrease in cell size.
Based on the experimentally determined cell diameters and
CFU counts for cultures used to prepare the cytoplasmic extracts
to detect c-di-AMP (see above Figure 7B) intracellular cyclic
dinucleotide concentrations of 2.860.6 mM for SEJ1 and
2.160.3 mM for the LAC* could be calculated, which increased
approximately 15-fold to 42.969.0 and 31.564.5 mM in the
isogenic gdpP mutant strains (Table 3).
Like c-di-GMP, increased levels of c-di-AMP affect the
ability of S. aureus to form a biofilm
In a variety of bacteria an increase in intracellular levels of the
related and well-characterized cyclic dinucleotide c-di-GMP,
stimulates the biosynthesis of adhesins, promotes biofilm formation
and inhibits various forms of motility [45]. No such functions have
yet been ascribed to c-di-AMP.
To investigate whether cellular levels of c-di-AMP affect the
ability of S. aureus to form a biofilm, cultures of WT SEJ1 and both
the silent gdpP mutant SEJ1DgdpP, and the marked gdpP mutant
SEJ1DgdpP::kan, were grown without shaking in 96-well plates
containing BHI 4% NaCl. Staining of adherent bacteria with
crystal violet revealed that the gdpP deletion strains formed
approximately 3-times more biofilm than the WT control strain
(Figure S8 in Text S1). However, it should be noted that neither
the WT nor the gdpP mutant LAC* strains formed robust biofilms
under these conditions. Nevertheless, this indicates that increased
cellular levels of c-di-AMP not only affect cell properties that allow
bacteria to grow in the absence of LTA but, like c-di-GMP, also
influence the production of components involved in biofilm
formation at least in some S. aureus background strains.
Discussion
Clear functions for the secondary messenger molecule c-di-
GMP, in controlling gene expression and the switch from
planktonic to sedentary lifestyles, have been established in a
diverse range of bacterial species [45]. It is now well documented
that this cyclic dinucleotide plays an important role in controlling
biofilm formation and virulence gene expression in a range of
bacteria, including important human pathogens such as Pseudomo-
nas aeruginosa [46]. Recently, it has also been suggested that this
signaling molecule, which is widespread in bacterial species but
apparently not found in higher eukaryotes, can act as a danger
Table 2. MIC for different antibiotics in mg/ml for LAC* and LAC*DgdpP::kan.
LAC* LAC* DgdpP Mode of action
Lysostaphin 0.25 2–4 Peptidoglycan – cleaves pentaglycine crossbridges
Oxacillin 32–64 256 Peptidoglycan – inhibits PBPs and peptidoglycan crosslinking
Penicillin G 0.2 .6.4 Peptidoglycan – inhibits PBPs and peptidoglycan crosslinking
Vancomycin 4 4 Peptidoglycan – binds to D-Ala D-Ala and prevents peptidoglycan crosslinking
Nisin 6.25–12.5 6.25–12.5 Antimicrobial peptide
Daptomycin 4–8 4 Membrane depolarization/disruption
MICs are defined as antibiotic concentration that leads to .75% growth inhibition as compared to growth without antibiotic.
doi:10.1371/journal.ppat.1002217.t002
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ulatory and immunostimulatory properties of c-di-GMP [47,48].
On the other hand, until very recently c-di-AMP had not been
recognized as a naturally occurring molecule in any living
organism. c-di-AMP was noticed for the first time in 2008 during
crystallization studies of the B. subtilis DNA binding protein DisA
[49,50]. Additional work confirmed that the N-terminal part of
DisA (DisA_N domain) is capable of synthesizing c-di-AMP in vitro
from two molecules of ATP [49]. Shortly afterwards, c-di-AMP
phosphodiesterase activity was ascribed to the B. subtilis protein
YybT using an in vitro assay system [39]. The first evidence for the
production of c-di-AMP by living cells came from a study on L.
monocytogenes, where this cyclic dinucleotide was detected in the
culture supernatant and identified as the molecule that stimulates
an IFN-b-mediated host immune response [40]. Very recently c-
di-AMP has also been detected in cytoplasmic extracts from S.
pyogenes and from B. subtilis [41,42]. In this study, we have
identified c-di-AMP within the cytoplasm of the Gram-positive
pathogen S. aureus and also quantified the amounts produced in vivo
in both laboratory and clinically relevant strains (Figure 7 and
Table 3). Intracellular c-di-AMP concentrations of 2 to 3 mM were
detected in the S. aureus cells, which are very similar to the
concentration of 1.7 mM reported for B. subtilis during vegetative
growth [41]. We also show in this study that GdpP functions in vivo
as a c-di-AMP-specific phosphodiesterase and provide experimen-
tal evidence that the S. aureus protein SAOUHSC_02407, which
was renamed DacA, is capable of producing c-di-AMP (Figure 7
and 9). Similar to what was observed with the c-di-GMP signaling
molecule, this study provides a link between this novel cyclic
nucleotide and cell wall properties in Gram-positive bacteria, as an
increase in c-di-AMP levels allows S. aureus to grow in the absence
of LTA and the CA-MRSA gdpP mutant strain shows an increased
resistance to the cell wall active antimicrobials oxacillin, penicillin
G and lysostaphin (Table 2) and an increase in the amount of
cross-linked peptidoglycan (Figure 8A). Our study also revealed
that c-di-AMP plays a role in controlling the cell size of S. aureus
(Figure 8B). Recently, Oppenheimer-Shaanan et. al have shown
that c-di-AMP levels increase 3-fold in B. subtilis at the onset of
sporulation and the authors suggested that this increase serves as a
positive signal for sporulation to proceed [41]. Since S. aureus does
not form spores, this particular function attributed to c-di-AMP
cannot apply to S. aureus. However, our observation that an increase
inc-di-AMPlevelsresultsina decreaseincell sizesuggestsperhaps a
more general function for c-di-AMP in progressing the cell cycle
and not just the sporulation process in Gram-positive bacteria. In
this respect, it is interesting to note that, in contrast to c-di-GMP, c-
di-AMP might be an essential constituent of the cell. Attempts to
disrupt the c-di-AMP cyclase DacA in L. monocytogenes were
unsuccessful [40]. Furthermore, screens for essential genes in
Mycoplasma pulmonis, Mycoplasma genitalium, Streptococcus pneumoniae as
well as S. aureus indicated that dacA is essential for cell viability
[51,52,53,54].
The c-di-AMP cyclase DacA and the c-di-AMP phosphodies-
terase GdpP are both predicted to be anchored to the bacterial
membrane and it seems likely that changes in the environment,
cell wall structures or in the membrane itself serve as cues to adjust
the intracellular cyclic dinucleotide levels. Bioinformatic analysis of
GdpP revealed that this protein contains a highly degenerated
PAS domain. PAS domains usually function as sensory domains
for detecting light, redox potential, oxygen, small ligands, and the
overall energy level of a cell, usually by way of an associated
cofactor [55]. A recent study has shown that the PAS domain of
the B. subtilis YybT protein is capable of binding the cofactor heme
and that this binding suppresses the phosphodiesterase activity in
vitro [56]. This indicates that the PAS domain of YybT is indeed
capable of sensing environmental changes and the most likely
output will be a change in c-di-AMP levels. In this regard it is
Figure 8. Peptidoglycan and microscopic analysis of LAC* and
LAC*DgdpP::kan strains. (A) Peptidoglycan analysis and quantification
of muropeptides. Peptidoglycan was purified from strains LAC* and
LAC*DgdpP::kan, digested with mutanolysin and muropeptides separated
by HPLC as described in the materials and methods section. Monomer,
dimerandtrimer&abovepeakareasashighlightedinFiguresS7AandS7B
in Text S1 were integrated and quantified using the Agilent Technology
ChemStationsoftwareandareshownaspercentagesofthetotalpeakarea
(minutes 20 and 145). The average values and standard deviations from
three experiments are plotted. For statistical analysis, a two-tailed two
sample equal variance Student’s t-test was performed and statistically
significant differences with p-values below 0.05 are indicated with an
asterisk (*). (B) Microscopic analysis of LAC*,LAC*DgdpP::kan, LAC*DgdpP::-
kan pRMC3 and LAC*DgdpP::kan pRMC3-gdpP. All strains were grown to
log-phase in TSB medium containing 100 ng/ml Atet, (plus chloramphen-
icol for plasmid-containing strains). Bacteria were stained with BODIPY-
vancomycin and prepared for microscopy analysis as described in the
materials and methods section. The diameters of 100 bacteria per strain
were measured in three independent experiments using the Improvision
Volocity software. The average diameter for WT LAC* bacteria was set to
100% and the diameters for the other strains are displayed as% of the WT.
Actual values of average diameters and standard deviation are listed in
Table 3. Larger fields of view are shown in Figure S7C in Text S1.
doi:10.1371/journal.ppat.1002217.g008
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the Ni-NTA columns during the purification process of the GdpP
protein, suggesting that the S. aureus protein is also capable of
binding heme.
GGDEF domains are typically associated with c-di-GMP
cyclases or phosphodiesterases and function to synthesize c-di-
GMP. Degenerated domains can also regulate the activity of
associated c-di-GMP phosphodiesterase domains [57]. The
GGDEF domain of GdpP has the highly divergent amino acid
sequence SSDQF, with substitutions of three of the five highly
conserved active site residues that are essential for GTP catalysis
[58]. The GGDEF domain of B. subtilis YybT can bind ATP and
slowly convert it to ADP [39]. However, this domain cannot
synthesize c-di-AMP and the ATP binding had no effect on the in
vitro phosphodiesterase activity contained within the DHH/
DHHA1 domains [39]. The biological relevance of the ATP
binding and hydrolysis activity of the degenerated GGDEF
domain remains to be determined. Indeed, we provide experi-
mental evidence in this study that argues against a role of any
potential ATPase activity for the function of the S. aureus GdpP
protein (Figure 6). At the same time our data suggest that this
domain can influence, independently of any ATPase activity, the
phosphodiesterase activity of the associated DHH/DHHA1
domains, as indicated by a decrease in in vitro phosphodiesterase
Table 3. Intracellular c-di-AMP concentration in different S. aureus strains.
Strain
Sample
number
ng c-di-AMP/ml
culture
CFU/ml
culture
Average cell
diameter (mm)
Average intracellular
c-di-AMP conc. (mM)
SEJ1 1 2.524 1.51E+09 1.13860.081 2.860.6
2 2.036 1.34E+09
3 2.124 2.00E+09
SEJ1DgdpP::kan 1 29.32 2.36E+09 0.87960.051 42.969.0
2 26.56 2.90E+09
3 31.44 3.71E+09
4S5 1 18.72 1.19E+09 1.14160.083 29.361.4
2 19.44 1.36E+09
3 18.72 1.26E+09
LAC* 1 2.864 2.11E+09 1.18860.025 2.160.3
2 2.344 1.98E+09
3 2.376 2.34E+09
LAC*DgdpP::kan 1 30.64 3.05E+09 0.96760.015 31.564.5
2 25.12 2.27E+09
3 27.32 3.28E+09
The molecular weight of c-di-AMP (free acid) is 658.4 g/l and the volume of a bacterial cell was calculated using 4/3 p r
3. The diameter of S. aureus cells was determined
experimentally by microscopic analysis and measuring the diameters of 100 cells each in three independent experiments.
doi:10.1371/journal.ppat.1002217.t003
Figure 9. Model of c-di-AMP synthesis and degradation in S. aureus. (A) S. aureus DacA (grey protein) synthesizes c-di-AMP (dark blue circles)
from ATP (light blue circles) and GdpP (red protein) hydrolyses c-di-AMP into 59-pApA (purple circles). This results in WT LTA-containing (depicted as
peach zone) S. aureus cells having an intracellular c-di-AMP concentration of approximately 2 to 3 mM. (B) LTA-negative S. aureus suppressor strains
survive by inactivating the phosphodiesterase activity of GdpP resulting in an increase in intracellular c-di-AMP levels. Next, it is assumed that at this
increased concentration c-di-AMP binds to a specific set of target proteins and either directly affects their activity or indirectly affects the expression
of other proteins, altogether compensating for the cell wall defect caused by the absence of LTA.
doi:10.1371/journal.ppat.1002217.g009
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GGDEF domain (Figure 6). Additional experiments are needed to
determine the mechanism by which the GGDEF domain
influences the activity of the downstream phosphodiesterase.
As mentioned above, c-di-GMP is typically synthesized by
GGDEF domain containing proteins and a search for this domain
highlighted two S. aureus proteins that could potentially function as
c-di-AMP cyclases. GdpP itself, which contains amino acid
alternations in crucial resides in this domain and extrapolating
from the rigorous in vitro analysis on the B. subtilis homologue
YybT, does not have cyclase activity. The second protein is GdpS
[44]. O’Gara and coworkers investigated the possibility that the
Staphylococcus epidermidis GdpS protein is a c-di-GMP cyclase but
with no success and consistent with this observation we show in
this study that c-di-GMP does not appear to be present in S. aureus
[44]. It is possible however, that GdpS may be involved in c-di-
AMP synthesis instead, a theory that is currently under investiga-
tion. In this regard it is interesting to note that, in contrast to the
gdpP deletion strain analyzed in this study that causes an increase
in biofilm formation (Figure S8 in Text S1), an S. epidermidis gdpS
mutant strain has a defect in biofilm formation caused by a
decrease in transcription of the polysaccharide-producing ica locus
[44].
While the exact number of S. aureus proteins involved in c-di-
AMP production and hydrolysis remains to be determined, it is
certain that GdpP and DacA are involved in this process (Figure 7).
Having shown that a deletion of gdpP results in increased
intracellular levels of c-di-AMP the question remains as to how
this suppresses the bacterial need for LTA. Rao et al., have
demonstrated that the alarmone ppGpp, which is produced during
the stringent response to cope with stress, inhibits the phospho-
diesterase activity of YybT in vitro [39]. Furthermore, disruption of
the GdpP homologues in Lactococcus lactis and B. subtilis renders
these bacteria more resistant to acid stress [39,59]. The deletion in
B. subtilis also increases the sporulation efficiency of cells that had
been exposed to a DNA damaging agent [39,41]. All these
observations indicate that an increase in intracellular c-di-AMP
levels allows bacteria to cope better under stress conditions.
Undoubtedly depleting LTA from the cell wall will place bacteria
under stress. While bacteria may not naturally be able to respond
to such a stress, one mechanism that allows bacteria to survive is
by irreversibly disrupting the function of GdpP and in this manner
increasing intracellular c-di-AMP levels (Figure 7B). By analogy
with c-di-GMP, we assume that c-di-AMP then acts as a secondary
messenger to up- or down regulate the activity or expression of
a certain set of target proteins (Figure 9) [45]. Alternatively,
c-di-AMP might also bind to RNA molecules to affect protein
expression, as in the case of c-di-GMP-dependent riboswitches
[60]. As an increase in c-di-AMP concentration in LTA depleted
cells has served to improve cell growth and division (Figure 3) it is
tempting to speculate that c-di-AMP is involved in regulating some
components of the cell division machinery. A function for c-di-
AMP in controlling cell division in S. aureus is also consistent with
our observations that gdpP mutant strains are smaller in size
(Figure 8B and Table 3). Therefore, an increase in intracellular c-
di-AMP appears to allow S. aureus cells to initiate cell division
before they have reached their normal size. Furthermore, the
increased resistance of a gdpP mutant LAC* strain to lysostaphin,
oxacillin and penicillin G and the decrease in monomeric
peptidoglycan subunits provides experimental evidence that
proteins involved in peptidoglycan synthesis are regulated by c-
di-AMP. It was also noted that three LAC* suppressor strains
contained WT gdpP sequences (Table S2 in Text S1). It is possible
that in these strains the molecular targets of c-di-AMP are mutated
instead of altering the concentration of the second messenger
molecule. While beyond the scope of this study, it will be
interesting to identify c-di-AMP target proteins in future studies, in
particular those involved in helping the bacteria cope with stress.
One could suppose that by interfering with c-di-AMP synthesis
cells may be less able to respond and cope with the stresses
encountered during infection. By identifying a way to combine this
inhibition with currently available drug treatments, it could be
possible to control even the most multi-drug resistant S. aureus
infections.
Inactivation of GdpP was the first step that allowed all five
sequenced suppressor strains to grow in the absence of LTA,
however several of the mutations acquired in subsequent steps are
interesting to note. Two suppressor strains acquired mutations that
lead to amino acid substitutions in the c-di-AMP cyclase DacA
(Table 1). These substitutions might function to improve cyclase
activity and, analogous to a gdpP deletion, this may result in an
overall increase in c-di-AMP levels. It is also plausible that these
mutations function to reduce the drastically increased levels of c-di-
AMP observed in suppressor strains, levels which could prove toxic
if not regulated properly. A third suppressor mutation resulted in an
amino acid substitution in the succinate dehydrogenase SdhA
(SAOUHSC_01104). SdhA is a TCA cycle enzyme and it is hard to
predict how alterations in a central metabolism enzyme could help
LTA-deficient bacteria to survive. The remaining two mutated
genes, encode for a putative permease (SAOUHSC_01358) and a
conserved hypothetical protein with sequence homology to a fusaric
acid transporter (SAOUHSC_02001) (Table 1). Premature stop
codons have arisen within these two proteins presumably
inactivating their function. Woodward et al have shown that over-
expression of multidrug resistance transporters results in increased
secretion of c-di-AMP into the supernatant of L. monocytogenes
cultures [40]. It is therefore plausible that disrupting the functions of
these two putative S. aureus transporters may again serve to increase
intracellular c-di-AMP levels.
Eukaryotic host cells often recognize essential bacterial cell
components as a means of detecting an infection. One well-studied
example of this is the recognition of peptidoglycan by the
intracellular host proteins Nod1 and Nod2, which upon detection
results in the activation of the NF-kB pathway and an immune
response [61]. Recently, Woodward and coworkers discovered
that c-di-AMP, which is released by L. monocytogenes inside host
cells, is also detected in the cytosol where it triggers a host immune
response [40]. S. aureus is another pathogen that is capable of
invading epithelial and endothelial cells through fibronectin
binding protein-mediated adherence to the host cell integrin
a5b1 and subsequent endocytosis [62]. Once inside the cell it is
equally likely that S. aureus secretes this potentially essential
nucleotide into the cytosol, a possibility that may then be exploited
by the host immune system. The eukaryotic proteins involved in
the detection of c-di-AMP and the mechanism leading to immune
activation remains to be determined as our current understanding
is only rudimentary [63].
Taken together we have shown that it is possible to create viable
LTA-negative strains of S. aureus that compensate for the loss of
this important polymer by increasing intracellular levels of the
secondary messenger c-di-AMP. The unambivalent identification
of c-di-AMP in the cytoplasm of S. aureus and the ability to regulate
its level opens up the exciting possibility of identifying target
proteins or other compounds through which this cyclic dinucle-
otide exerts its function and regulates cellular processes. This is
especially intriguing for Gram-positive pathogens such as S. aureus,
S. pneumonia, S. pyogenes and L. monocytogenes considering that
c-di-AMP may be essential for cell viability. Further studies are
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to ultimately discover what targets are altered in response to a
deletion of LTA. This will hopefully help us to more fully
understand the biological significance of this polymer and to
identify novel essential cellular survival mechanisms that could be
exploited as therapeutic drug targets.
Materials and Methods
Bacterial strains and culture conditions
Strains used in this study are listed in Table S3 in Text S1 and
primers used for cloning in Table S4 in Text S1. E. coli and B.
subtilis strains were grown in LB and S. aureus strains were grown in
TSB medium at 37uC with aeration, if not otherwise stated. When
required, media were supplemented with antibiotics and inducers
as indicated in Table S3 in Text S1. Details on plasmid and strain
constructions are provided in the supplementary Materials and
Methods section in Text S1.
Growth curves and determination of CFUs
WT and LTA suppressor strains were grown overnight in TSB
medium. Unsuppressed DltaS strains were grown in TSB
containing either 7.5% NaCl or 40% sucrose. Overnight cultures
were washed three times in the appropriate medium and diluted to
a starting OD600 of 0.05. Cultures were incubated at 37uC with
aeration and OD600 values determined at 2 h intervals. Cultures
containing ltaS under IPTG inducible control were grown
overnight in the presence of IPTG and the appropriate antibiotics.
Bacteria were washed three times in TSB and diluted to an OD600
of 0.05 in 5 ml TSB with or without 1 mM IPTG and 100 ng/ml
Atet as appropriate and OD600 values determined. Where stated,
the cultures were diluted after 4 h 1:100 into fresh medium with
the appropriate antibiotics and inducers to maintain cultures in the
exponential growth phase and growth continued for a further 6 h.
The 4 h time point is then represented as T=0. Growth curves
were performed in triplicate and representative graphs are shown.
CFUs per ml culture were determined by emulsifying a colony in
1 ml TSB, normalizing the OD600 to 0.05, performing serial
dilutions and plating 100 ml on the appropriate plates. Plates were
then incubated at 30uCo r3 7 uC as indicated and colonies were
enumerated after overnight growth. Counts were performed twice
with representative figures stated in the text.
Whole genome sequencing
For whole genome sequence determination, chromosomal DNA
was isolated from the S. aureus reference strain SEJ1 and the 5
suppressor strains 4S4, 4S5, 4N1, 4N2 and 5S4. Sequences were
determined using a SOLiD 3 System (Applied Biosciences) and
DNA fragment libraries. Fifty bp fragment libraries were
generated by mechanical shearing, treated and coupled to beads
using emulsion PCR and deposited on glass slides following
protocols supplied by Applied Biosciences. The generated reads
resulted in genomic coverage of between 140x and 213x and have
been submitted to the ENA Sequence Read Archive (SRA) under
accession ERP000528 (http://www.ebi.ac.uk/ena/data/view/
ERP000528). Reads from SEJ1 were aligned to the known
genome sequence of S. aureus strain NCTC8325 with the BioScope
mapping pipeline (Applied Biosystems) using an anchor length of
25 bp allowing 2 mismatches. Next the reads from the suppressor
strains were individually aligned to NCTC8325 using the same
alignment procedure. Using these analysis tools, large DNA
deletions in place of the prophage sequences and the spa gene as
well as 84 point mutations with high confidence scores were
detected in all strains (SEJ1 and the 5 suppressor strains) when
compared to the NCTC8325 genome sequence. Of these 84
mutations, 76 were identical to those listed in the recently
published paper on the RN4220 genome sequence [34]. Of the 8
that differed, 7 were located in a highly repetitive genome region
and are likely to represent misalignments of reads. Of the extra 45
snps identified by Nair et. al., [34], a number are caused by
insertion or deletion events, mutations we could not detect because
of limitations of the analysis software and due to the use of a
fragment library rather than using mate-pairs. Ten additional
mutations, identified using the BioScope diBayes pipeline (Applied
Biosystems) and ‘high’ call stringency setting, were present in the
suppressors strains but absent in strain SEJ1 and these mutations
are described in detail in the results section. Suppressor strains
specific differences were verified by re-sequencing the genes in
question at the MRC Clinical Science Centre Sequencing Facility
at Imperial College London.
Western blot, autolysis assays, zymogram assays, biofilm
assays, minimum inhibitory concentrations, phase
contrast and fluorescence microscopy
These assays were performed using standard procedures and
details can be found in the supplementary Materials and Methods
section in Text S1.
Protein purification
His-tagged S. aureus GdpP protein variants and the B. subtilis
DisA protein were purified from 1 to 2 liter induced E. coli
BL21(DE3) cultures containing the respective pET28b expression
vectors (Table S3 in Text S1). Protein induction and purification
was performed as described in Rao et al. with minor modifications
and details can be found in Text S1 [39].
In vitro c-di-AMP phosphodiesterase activity assay
The enzymatic activities of the different purified GdpP protein
variants was determined by incubating 20 mM c-di-AMP (BioLog)
with 1 mM purified protein in buffer containing 50 mM Tris
pH 8.5, 20 mM KCl and 0.1 mM MnCl2. Enzyme reactions were
stopped at the indicated time by the addition of an equal volume
of 0.1 M EDTA pH 8 and incubation for 3 to 5 min at 95uC.
Enzymatic activity was determined by separating 15 ml of the
reaction mixtures by HPLC (Agilent LC1200) using a Luna
15062, 3 mm particle size RP C-18 column and a 0.1 M
triethylamine acetic acid pH 6.1 (Buffer A) and 80% acetonitrile
containing 20% buffer A (Buffer B) solvent system. The column
temperature was set to 35uC and the flow rate to 0.25 ml/min and
a constant buffer B concentration of 5% was used for the runs.
Nucleotides were detected at A254 and authentic c-di-AMP and 59-
pApA (BioLog) were used as standards to determine nucleotide
specific retention times.% c-di-AMP hydrolysis was calculated
based on integrated nucleotide peak areas. Four independent
experiments were performed (using proteins from two separate
purifications) and the average and standard deviation of all four
values is plotted.
Preparation of bacterial extracts for c-di-AMP
measurements
Overnight cultures of S. aureus cells were diluted to a starting
OD600 of 0.05 and grown for 4 h at 37uC with aeration. Cultures
were adjusted to an approximate OD600 of 2, CFU counts
determined by plating appropriate dilutions on TSA plates and
bacteria from a 10 ml culture aliquot were also collected by
centrifugation, washed and freeze dried to determine the dry
weight, for normalization purposes. A 5 ml aliquot from the same
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9,0006g for 5 min. The pellet was suspended in 1 ml ice-cold
extraction buffer (acetonitrile/MeOH/H2O - 40:40:20; LC-MS
gradient grade, VWR) containing 0.58 mM internal
13C
15N
isotope labeled c-di-AMP standard. Samples were snap frozen
with liquid N2 for 15 sec before being heated to 95uC for 10 min.
Samples were mixed with 0.5 ml of 0.1 mm glass beads and lysed
in a Fast-Prep machine 2 x for 45 sec at setting 6 (FP120, MP
Biomedicals, LLC). Glass beads were separated by centrifugation
at 17,0006g for 5 min at 4uC. The supernatant was removed and
stored at 4uC and the remaining glass beads/cell debris mixture
was washed with 1 ml extraction buffer without internal standard,
incubated on ice for 15 min and again lysed. Samples were once
again spun and the supernatant combined with the previous one.
Glass beads were washed with 1 ml extraction buffer, incubated
on ice for 15 min and centrifuged. All supernatants were
combined and samples dried at 40uC under a stream of N2 and
stored at 280uC. E. coli overnight cultures were diluted 1:100 into
fresh LB medium and grown at 37uCt oa nO D 600 of 0.5 at which
point 1 mM IPTG was added and cultures were grown for a
further 3 h. For normalization purposes, culture aliquots corre-
sponding to an OD600 of 2 were withdrawn, washed once in PBS
pH 7.4, suspended in 800 ml 0.1 M NaOH and heated to 95uC for
15 min. The samples were centrifuged for 5 min at 17,0006g and
the protein content of the supernatant was determined using a BCA
assay kit (Pierce). Aliquots corresponding to an OD600 of 20 were
withdrawn from the same cultures and centrifuged for 5 min at
9,0006g. The pellet was suspended in 300 ml ice-cold extraction
buffer (acetonitrile/MeOH/H2O; 40:40:20) containing cXMP
(BioLog) as an internal standard at a final concentration of
200 ng/ml. Samples were frozen with liquid nitrogen for 15 sec
and afterwards heated to 95uC for 10 min. Samples were
centrifuged at 17,0006g for 5 min at 4uC and the supernatant
removed. The pellet was suspended in 200 ml extraction buffer
without cXMP, incubated on ice for 15 min and centrifuged. The
supernatant was combined with the previous one and the pellet was
once again suspended in 200 ml extraction buffer followed by a
15 min incubationon ice and a centrifugation step. Allsupernatants
were combined and dried at 40uC under a flow of N2. The c-di-
AMP concentration was determined based on a c-di-AMP standard
curve and values are presented as ng c-di-AMP/mg E. coli protein.
Preparation of isotope labeled c-di-AMP
For the synthesis of
13C
15N isotope labeled c-di-AMP, 1 mM
rDisA was incubated with 500 mM adenosine-
13C
15N-59-triphos-
phate in 10 mM Tris-HCl, pH 7.5, 10 mM MgCl2 and 0.1% BSA
for 18 h at 30uC with gentle mixing (300 rpm). Based on an
identical experiment using unlabeled ATP as the substrate, it was
deduced that substrate turnover is complete under these
conditions. The reaction was stopped by heating samples to
95uC for 15 min and the suspension was clarified by centrifugation
(20,8006g; 10 min; 4uC). The concentration of
13C
15N-c-di-AMP
in the supernatant was determined by measuring the absorption at
259 nm (e259 nm=30,000 M
21cm
21). Further purification steps
were not necessary for the use of
13C
15N-c-di-AMP as an internal
standard and were therefore omitted.
Quantification of c-di-AMP by LC-MS/MS
c-di-AMP was detected and quantified by LC-MS/MS using a
similar protocol as published previously for the detection of c-di-
GMP [43]. Details are given in the supplementary Materials and
Methods section in Text S1.
Muropeptide analysis by HPLC
For muropeptide analysis, 1 liter TSB medium was inoculated
with overnight cultures of strains LAC* (AH1263) or LAC*D
gdpP::kan (ANG1961) to an OD600 of 0.06. The cultures were grown
at 37uC to mid-log phase (OD600 of approximately 1.5), cooled on
ice and bacteria subsequently collected by centrifugation. Peptido-
glycan was purified using a well-established method, which we have
used previously [64,65]. Next, 5 mg purified peptidoglycan was
digested in a final volume of 1.24 ml in 12.5 mM phosphate buffer
pH 5.9 with 50 mg mutanolysin from Streptomyces globisporus (Sigma)
for 20 h at 37uC. The suspension was subsequently boiled for 5 min
and the insoluble material removed by centrifugation for 5 min
at 17,0006g and the soluble fraction stored at 4 or 220uC.
Immediately before HPLC analysis, a portion of the soluble
muropeptide fraction was mixed with an equal volume of 0.5 M Na
boratebufferpH 9 and reduced for30 minatRTbythe addition of
sodium tetraborohydride. Subsequently the pH was adjusted to 2–3
with 20% phosphoric acid and 100 ml was analyzed by HPLC using
a3 mm-particle-size 120A pore size octyldecyl silane Hypersil
25064.6 mm C18 column equipped with a 1064 mm guard
column made of the same material (Thermos Electron Corpora-
tion). The column temperature was set to 52uC and a sodium
phosphate/methanol buffer system and gradient conditions were
used as previously described with the exception that the sodium
azide was omitted from buffer A [64,66]. HPLC traces were
recorded at 205 nm and the muropeptide profile from three
independently grown cultures was determined and a representative
graph is shown. For quantification purposes, the area of muropep-
tide peaks was integrated and quantified using the Agilent
Technology ChemStation software and shown as percentage of
the total (min 20 and 145) peak area and the average values and
standarddeviationsofthethreeexperimentsisgiven.Thetwo-tailed
two sample equal variance Student’s t-test was used to determine
statistically significant differences between muropeptide peak areas
and statistically significant differences with p-values below 0.05 are
indicated with an asterisk (*).
Gene accession numbers (Swissprot identities)
S. aureus NCTC8325: ltaS - SAOUHSC_00728; gdpP -
SAOUHSC_00015; dacA - SAOUHSC_02407; gdpS -
SAOUHSC_00760; gene containing suppressor mutation 2 -
SAOUHSC_01104; mutation 3 - SAOUHSC_01358; mutation 4
- SAOUHSC_02001; atl – SAOUHSC_00994; B. subtilis str.168:
yybT - BSU40510; disA - BSU00880; L. monocytogenes str. EGD-e:
dacA – lmo2120; Streptococcus pyogenes SF370: dacA - Spy1036
Supporting Information
Text S1 Supplementary information. This file contains a
supplementary Materials and Methods section, supplementary
Figures S1 to S8 and supplementary Tables S1 to S4.
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